MétaCan
Menu
← Back to cohort
Record W7117255184 · doi:10.1002/alz70855_105101

The Multifactorial Impact of ApoE4 on Alzheimer's Pathology and Cognitive Decline

2025· article· en· W7117255184 on OpenAlexaff
Aya Arrar, Mark Longmuir, Kate M. Onuska, Bryan Lung, Scheila Schmidt, Amr Eed, Kellly Summers, Arash Salahinejad, Ravi S. Menon, Ali R. Khan, Lisa M Saksida, Timothy J Bussey, Tallulah Andrews, Taylor W. Schmitz, Vânia F. Prado, Marco AM Prado

Bibliographic record

VenueAlzheimer s & Dementia · 2025
Typearticle
Languageen
FieldMedicine
TopicAlzheimer's disease research and treatments
Canadian institutionsLawson Health Research InstituteRobarts Clinical TrialsWestern University
Fundersnot available
KeywordsCognitive declineCognitionNeurodegenerationDiseaseBiomarkerCognitive impairment

Abstract

fetched live from OpenAlex

Abstract Background Apolipoprotein E (ApoE) isoforms differentially regulate Aβ and tau pathology in Alzheimer's disease (AD). However, most preclinical models do not recapitulate the combined impact of Aβ, tau, and ApoE on cognitive function and disease progression. To overcome this, we developed new mouse models harbouring humanized variants of the ApoE genotypes (ApoE3, ApoE4), hApp (App WT , App NL or App NL‐F ) and hMAPT (tau), and evaluated whether their interactions influence cognition, brain structure, and pathological load. Method Methods used include single nuclei RNA sequencing (snRNAseq), magnetic resonance imaging (MRI), immunofluorescence microscopy, ELISAs, and Western Blotting. Attentional function was assessed using the cross‐species Continuous Performance Task, an automated touchscreen test. Result Biochemical and immunofluorescence analyses confirm that ApoE genotype interacts with both Aβ and tau to drive distinct pathogenic trajectories. At 6 months, App NL‐F /ApoE4 mice exhibit higher cortical levels of insoluble Aβ42 compared to their ApoE3 counterparts, indicating that ApoE4 accelerates amyloidogenic processes. This trend persists at 9 and 12 months, where App NL‐F /ApoE4 mice show increased insoluble Aβ42 levels, plaque burden and plaque size compared to App NL‐F /ApoE3 mice. Additionally, cortical levels of soluble and insoluble total tau are elevated in App NL‐F /ApoE4 mice relative to App NL‐F /ApoE3 mice at 9 and 16 months, respectively. MRI reveals reduced grey matter volume in fronto‐cortical regions of 6‐month‐old App NL‐F /ApoE4 mice compared to App NL /ApoE3 mice. snRNA‐seq confirms a reduction in cortical excitatory neurons, and an upregulation of gliosis in App NL‐F /ApoE4 mice. Finally, App NL‐F /ApoE4 mice exhibit attentional deficits on CPT as early as 6 months, with these impairments persisting at 9 and 12 months relative to App NL‐F /ApoE3 mice. Pathology was negligible at all timepoints in App NL (ApoE3 and ApoE4) and App WT mice, suggesting that Aβ toxicity drives the pathogenic interactions with ApoE. Conclusion These findings highlight the multifactorial impact of ApoE4 in AD, demonstrating that humanized App NL‐F /MAPT/ApoE4 mice exhibit biochemical and imaging biomarkers of pathology and a time course of neurodegeneration and cognitive dysfunction that reproduces a human‐like phenotype of late onset AD. This work underscores the value of combining these novel mouse models with translational imaging and cognitive biomarkers for understanding the relationship between pathophysiology and high‐level cognitive function.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.007

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.001
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0010.000
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0010.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.031
GPT teacher head0.363
Teacher spread0.332 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueAlzheimer s & Dementia→Same topicAlzheimer's disease research and treatments→French-language works237,207→